AKT1 and non-small cell lung carcinoma: Evidence from studies of the rat Solt-Farber hepato-carcinogenesis model and clinical NSCLC samples suggest that upregulation of NRF2 occurs early during tumourigenesis, and that its constitutive activation probably supports the actions of oncogenic KRAS and hyperactivated PKB/Akt.